Skip to main content
. 2021 Apr 18;10(8):1761. doi: 10.3390/jcm10081761

Table 4.

Baseline and 6-week FACT-L results for the two groups.

ETG Pre ETG Post p * CG Pre CG Post p * Between Group Δ Post-Pre p Effect Size
PWB 20.5
[13.0–23.0]
18.5
[15.0–24.0]
<0.84 25.5
[22.0–28.0]
19.5
[16.5–25.0]
<0.02 0.02 0.753
SWB 22.5
[18.0–25.0]
20.0
[18.0–24.0]
<0.40 25.5
[22.0–28.0]
19.5
[16.5- 25.0]
<0.93 0.64 −0.459
EWB 17.0
[8.0–22.0]
16.5
[12.0–21.0]
<0.94 24.5
[19.0- 25.5]
23.5
[18.5–25.5]
<0.34 0.50 −0.524
FWB 18.5
[16.0- 21.0]
19.5
[15.0- 24.0]
<0.56 17.5
[15.5–19.5]
19.0
[15.5–22.0]
<0.44 0.78 −0.251
LC 17.5
[16.0–24.0]
22.5
[18.0–24.0]
<0.17 17.5
[15.5–22.0]
22.0
[15.5–5.0]
<0.11 0.10 0.592
FACT-L 91.0
[76.0–113.0]
92.5
[77.0–108.0]
<0.87 99.5
[95.5–118.0]
106.0
[84.5–115.0]
<0.22 0.49 0.058

PWB: physical well-being; SWB: social well-being; EWB: emotional well-being; FWB: functional well-being; LC: lung cancer; FACT-L: Functional Assessment of Cancer Therapy-Lung; *—within-group analysis (Wilcoxon signed-rank test); †—between-group analysis (Mann-Whitney U test).